期刊文献+

高危HPV/TCT检测在宫颈上皮内瘤变筛查中应用 被引量:1

Application of high-risk HPV/TCT in screening for cervical intraepithelial neoplasia
原文传递
导出
摘要 目的高危型人乳头瘤病毒(human papillomavirus,HPV)感染是发生宫颈鳞状上皮内瘤变的必要不充分条件,敏感性高但特异性低。本研究探讨高危型HPV/液基细胞学(liquid-based cytology,TCT)检测在宫颈上皮内瘤变筛查中临床价值,为宫颈癌早期筛查提供参考。方法收集2018-03-09-2018-05-21青岛大学医学院附属医院162例患者临床资料,活检前宫颈高危HPV阳性并TCT阴性,分析其病毒类型、上皮内瘤变分级及年龄分布特征。结果162例患者中,高危HPV阳性率为98.57%(160/162),TCT阳性率为74.90%(121/162),χ^2=40.78,P<0.001。HPV敏感度为90.74%(147/162),特异度为85.18%(138/162),假阴性率为6.79%(11/162)。单一型高危病毒感染共22例,其中HPV1618例(43.90%),HPV184例(9.75%),多种高危病毒感染14例(34.14%),高危和低危混合感染5例(12.19%)。病理结果均为宫颈上皮内瘤样变,其中CINⅠ20例,CINⅡ20例,CINⅢ1例,CINⅡ并累及腺体3例,其中<30岁11例,所占比例最高(55%)。结论宫颈或阴道炎症、HPV病毒感染均会引起宫颈细胞学异常,对于TCT检查异常患者进行HPV病毒检测可提高宫颈上皮内瘤变准确率,且要重视年龄较小的患者。 OBJECTIVE High-risk human papillomavirus(HPV)infection is a necessary and insufficient condition for cervical squamous intraepithelial neoplasia.It has high sensitivity but low specificity.This study explores the clinical value of high-risk HPV/liquid-based cytology(TCT)in screening cervical intraepithelial neoplasia,and provides reference for early screening of cervical cancer.METHODS A total of 162patients in the Affiliated Hospital of Medical College of Qingdao University from March 09,2018to May 21,2018were collected.HPV was positive and TCT was negative before biopsy.The viral type,grade of intraepithelial neoplasia and age distribution were analyzed.RESULTS Among the 162patients,the high-risk HPV positive rate was 98.57%(160/162),the cytology positive rate was 74.90%(121/162),χ^2=40.78,P<0.001.The HPV sensitivity was 90.74%(147/162),the specificity was 85.18%(138/162),and the false negative rate was 6.79%(11/162).There were 22cases of single-type high-risk virus infection,including 18cases(43.90%)of HPV16,4cases(9.75%)of HPV18,14cases(34.14%)of high-risk virus infection,and 5cases(12.19%)of high-risk and low-risk mixed infection.Pathological results showed that all were cervical intraepithelial neoplasia,including 20cases of CINⅠ,20cases of CINⅡ,1case of CINⅢ,3cases of CINⅡinvolving glands,of which 11cases were<30years old with the highest proportion(52.38%).CONCLUSIONS Cervical or vaginal inflammation,HPV virus infection can cause cervical cytology abnormalities.HPV virus detection in patients with abnormal cytology can improve the accuracy of cervical intraepithelial neoplasia,and it should pay attention to younger patients.
作者 王雪鹤 孙华芹 付凯 马红 WANG Xue-he;SUN Hua-qin;FU Kai;MA Hong(Department of Gynaecology,Songshan Hospital of Qingdao University,Qingdao 266021,P.R.China;Department of Gynaecology,Affiliated Hospital of Qingdao University,Qingdao 266003,P.R.China)
出处 《社区医学杂志》 2019年第21期1325-1327,共3页 Journal Of Community Medicine
关键词 宫颈上皮内瘤变 高危病毒感染 液基细胞学检查 人乳头瘤病毒 cervical intraepithelial neoplasia high risk viral infection liquid-based cytology human papillomavirus
  • 相关文献

参考文献14

二级参考文献107

  • 1宫海霞,张新颖,隋丽丽,张艳芳.TCT筛查、阴道镜活检及病理在宫颈癌筛查中的应用[J].中外医疗,2008,27(27). 被引量:5
  • 2郑莹,彭芝兰,楼江燕,王和.宫颈癌及癌前病变HPV-16存在状态检测的研究[J].中国肿瘤临床,2006,33(17):961-965. 被引量:10
  • 3孙海,耿建,陈龙邦.紫杉类药物耐药机制的研究进展[J].医学研究生学报,2007,20(3):315-318. 被引量:11
  • 4Monsonego J, Hudgens MG, Zerat L, et al. Risk assessment and clin- ical impact of liquid - based cytology, oncogenic human papiUomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (theFASE study) [J]. Gynecologic Oncology, 2012, 125 (1): 175 - 180.
  • 5Baussano I, ElfstrSm KM, Lazzarato F, et al. Type - specific human papillomavirus biological features: Validated model - based estimates [J]. PLoSOne, 2013, 8 (11): e81171.
  • 6Matah M, Sarecn S. Detection of HPV by PER - A novel step in the pre- vention of cancer cervix [ J ]. The Journal of Obstetrics and Gynecology of India, 2012, 62 (2) : 188 -191.
  • 7Jaisamrarn U, Castellsagu6 X, Garland SM, et al. Natural history of progression of HPV infection to cervical lesion or clearance: Analysis of the control arm of the large, randomised PATRICIA study [ J ]. PLoS One, 2013, 8 (11): e79260.
  • 8Burger EA, KornCr H, Klemp M, et al. HPV mRNA tests for the de- tection of cervical intraepithelial neoplasia: A systematic review [ J ]. Gynecologic Oncology, 2011, 120 (3): 430-438.
  • 9Cuzick J, Bergeron C, yon Knebel Doeberitz M, et al. New technolo- gies and procedures for cervical cancer screening [ J]. Vaccine, 2012, 30 (Suppl5) : F107 -116.
  • 10Zhan FH, Lewkowitz AK, Chen F, et al. Pooled analysis of a self - sampling HPV DNA Test as a cervical cancer primary screening method [J]. Journal of the National Cancer Institute, 2012, 104 (3) : 178 - 188.

共引文献571

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部